Polypharmacy—the concurrent use of multiple medications—is a global challenge, and the active participation of patients and their families in decisions about medication use is essential. In a new study, researchers at University of Tsukuba, Hokkaido University of Science, and Keio University developed and validated a Japanese version of the revised Patients’ Attitudes Towards Deprescribing (rPATD). It is an internationally recognized questionnaire designed to assess attitudes toward medication reductions among patients and their caregivers.
Polypharmacy—the concurrent use of multiple medications—is a global challenge, and the active participation of patients and their families in decisions about medication use is essential. In a new study, researchers at University of Tsukuba, Hokkaido University of Science, and Keio University developed and validated a Japanese version of the revised Patients’ Attitudes Towards Deprescribing (rPATD). It is an internationally recognized questionnaire designed to assess attitudes toward medication reductions among patients and their caregivers.
